Turmeric (Curcuma longa)

Active Compounds

Curcuminoids: The collective term for the three principal polyphenols in turmeric rhizome: curcumin, demethoxycurcumin, and bisdemethoxycurcumin. Curcumin is the most studied and is considered the primary bioactive component. Commercial curcuminoid extracts are mostly curcumin: capsules analysed in one dose-escalation trial were 75% curcumin, 23% demethoxycurcumin and 2% bisdemethoxycurcumin, which the authors described as typical of commercial products (Lao et al., BMC Complementary and Alternative Medicine, 2006). In the whole spice the fraction is small and variable: total curcuminoids ranged from about 2.3% to 9.2% by weight across four Indian turmeric varieties (Jayaprakasha et al., Journal of Agricultural and Food Chemistry, 2002), and retail turmeric powders averaged 3.14% curcumin (Tayyem et al., Nutrition and Cancer, 2006), so typical dietary turmeric use provides relatively modest curcuminoid amounts.

Bioavailability challenge — glucuronidation: Curcumin undergoes rapid and extensive phase II metabolism in the intestinal wall and liver. Glucuronidation (conjugation with glucuronic acid) is the predominant pathway, with some sulfation, producing curcumin glucuronides and sulfates that are thought to be less active; poor absorption, rapid metabolism and rapid elimination together keep plasma and tissue levels low (Anand et al., Molecular Pharmaceutics, 2007). In one dose-escalation study, no curcumin was detected in serum after single doses up to 8 g, and only low levels in two volunteers given 10–12 g (Lao et al., 2006). This rapid glucuronidation is the primary reason standard turmeric powder and unformulated curcumin show limited systemic effects.

Piperine (from black pepper) and bioavailability enhancement: Piperine, the alkaloid responsible for black pepper’s pungency, inhibited glucuronidation and other drug-metabolizing reactions in rat studies (Atal et al., Journal of Pharmacology and Experimental Therapeutics, 1985). In a small pharmacokinetic study in rats and healthy human volunteers, 2 g of curcumin alone produced serum levels that were undetectable or very low in humans, while co-administration of 20 mg piperine raised curcumin bioavailability by about 2,000% (Shoba et al., Planta Medica, 1998); one of its authors founded Sabinsa, which sells piperine as BioPerine. The proposed mechanism is inhibition of UDP-glucuronosyltransferases (UGTs), shown in rats, and of intestinal P-glycoprotein efflux, shown in human cell and microsome studies (Bhardwaj et al., 2002). Even with piperine, free curcumin remained undetectable in plasma in a later trial (Volak et al., 2013).

Fat co-ingestion: Curcumin is lipophilic (fat-soluble) and poorly soluble in water, which is why several enhanced formulations use lipid or phospholipid carriers. Whether simply eating turmeric with a fatty meal raises absorption meaningfully has been little studied in humans. Traditional Indian cooking often prepares turmeric in ghee or oil.

Enhanced-bioavailability formulations: Several technologies have been developed to circumvent curcumin’s bioavailability limitations:

• Phospholipid complexes (e.g., Meriva, Phytosome): binding curcumin to phosphatidylcholine creates a more absorbable amphiphilic structure; in a randomized crossover study, total curcuminoid absorption from Meriva was about 29-fold higher than from the corresponding unformulated curcuminoid mixture, although only phase-2 metabolites were detectable in plasma and the gain was larger for demethoxycurcumin than for curcumin itself (Cuomo et al., Journal of Natural Products, 2011)
• Nanoparticle and nanostructured lipid carriers: encapsulation in nano-sized lipid vehicles improves solubility and permeability
• Self-emulsifying drug delivery systems (SEDDS): spontaneously form microemulsions in GI fluid, improving dispersibility
• Theracurmin (amorphous curcumin dispersed in colloidal submicron particles): in healthy volunteers given 30 mg of curcumin in either form, plasma AUC was 27-fold higher than with curcumin powder (Sasaki et al., Biological and Pharmaceutical Bulletin, 2011)
• BCM-95 (Biocurcumax): curcumin combined with turmeric essential oils; a manufacturer-run pilot crossover study reported relative bioavailability about 6.93-fold that of normal curcumin (Antony et al., Indian Journal of Pharmaceutical Sciences, 2008)

These multipliers come from separate studies, each against its own unformulated comparator, with different doses, analytes (total curcuminoids versus curcumin) and assay methods. They are not a ranking: a 29-fold figure for one product and a 7-fold figure for another do not mean the first delivers four times as much curcumin.

Essential oil fraction: Turmerones (ar-turmerone, α-turmerone, β-turmerone) are sesquiterpene ketones that typically dominate turmeric’s volatile oil, although its composition varies considerably between samples and chemotypes (Dosoky et al., Foods, 2019). Ar-turmerone increased neural stem cell proliferation in rat cell cultures and in rats given it by brain injection (Hucklenbroich et al., Stem Cell Research & Therapy, 2014) and may contribute to traditional medicinal properties independent of curcuminoids.

Turmeric and Black Pepper

Black pepper is added to turmeric to slow the breakdown of curcumin, so more of it reaches the bloodstream. The evidence comes from small pharmacokinetic studies rather than outcome trials, and the same mechanism raises the risk of drug interactions.

How much pepper: The original study paired 20 mg of piperine with 2 g of curcumin, a 100:1 ratio (Shoba et al., 1998). At the average 4.4% piperine content of retail black pepper (Lee et al., 2021), 20 mg is roughly 0.5 g of ground pepper, about a quarter teaspoon. Supplements usually add a standardized piperine extract instead; check the milligrams per serving on the label.

In food: Indian cooking often combines turmeric with fat and pepper, as do golden milk recipes. Whether culinary amounts of pepper raise curcumin absorption meaningfully has not been measured directly.

The trade-off: Piperine inhibits CYP3A4, P-glycoprotein and glucuronidation, so it can raise levels of some medicines as well as curcumin. Three of the seven products tested in a US series of turmeric-associated liver injury also contained piperine (Halegoua-DeMarzio et al., 2023). Anyone on prescription drugs should check a piperine-containing curcumin product with a pharmacist.

Evidence for Purported Benefits

Typical Use and Dosing

Photo: Simon A. Eugster, CC BY-SA 3.0, via Wikimedia Commons

Culinary use: Retail turmeric powder averages roughly 3% curcumin (Tayyem et al., 2006). A teaspoon of ground turmeric weighs about 3 g (USDA FoodData Central), so standard culinary use (1/4 to 1 teaspoon, about 0.75–3 g per serving) provides roughly 20–100 mg curcumin — far below the gram-level daily doses used in many clinical trials of unformulated curcumin. Traditional Indian cooking often pairs turmeric with fat and black pepper, though the absorption benefit at culinary amounts has not been measured directly.

Standard curcumin (unformulated): trials have generally used gram-level daily doses, often divided and taken with meals. Clinical trial evidence for standard curcumin is limited due to bioavailability issues; any effects of this form may come largely from its action in the gut (Lopresti, 2018).

Piperine-enhanced formulations: the original pharmacokinetic study paired 2 g curcumin with 20 mg piperine, a 100:1 ratio (Shoba et al., 1998); commercial “black pepper curcumin” products vary. Check the label for the piperine amount per serving.

Enhanced-bioavailability formulations (higher plasma exposure in pharmacokinetic studies): follow the label, and compare products by curcumin content rather than total formulation weight.

• Meriva (curcumin-phosphatidylcholine): labels give both the complex weight and the curcumin it supplies; compare on the curcumin figure
• Theracurmin: read the label as curcumin content, not powder weight. The formulation in the original pharmacokinetic study was 10% curcumin by weight (Sasaki et al., 2011), so 180–360 mg of that powder supplies 18–36 mg curcumin. An 18-month trial used Theracurmin providing 90 mg curcumin twice daily (Small et al., American Journal of Geriatric Psychiatry, 2018). Lower curcumin weight than unformulated doses, but higher plasma exposure
• BCM-95: dose by the curcumin content stated on the label; published dosing data are limited and largely manufacturer-linked

For a turmeric-based drink, see the golden milk recipes, which pair it with black pepper and a fat.

Product Selection Criteria

• Formulation transparency: The single most important selection criterion. Standard turmeric powder and unformulated curcumin extract are likely to have minimal systemic bioavailability. Prefer products using an enhanced-bioavailability technology (Meriva, Theracurmin, BCM-95, Longvida, or piperine-combined formulations) with published pharmacokinetic data. The roundup of organic turmeric and curcumin supplements compares products on these formulations, including piperine-free options.
• Curcuminoid standardization: Products should specify percentage of curcuminoids (not just “turmeric extract”) — extracts used in trials of standard curcumin, such as the one in Lao et al. (2006), were standardized to at least 95% curcuminoids.
• Piperine products: If using piperine-enhanced formulations, ensure the piperine dose per serving is specified. Be aware of the drug interaction implications of piperine if taking other medications.
• Third-party testing: NSF International or USP certification verifies identity, curcuminoid content accuracy, and that heavy metals are below set limits; Informed Sport screens only for banned substances. Lead is the main concern for turmeric: lead chromate pigment added to deepen the color has been found in turmeric sampled across South Asia (Forsyth et al., Science of the Total Environment, 2024), and FDA lists turmeric from several firms for detention over lead (FDA Import Alert 99-42).
• Excipients and carrier oils: For lipid-based formulations, the quality of carrier oils (non-oxidized, cold-pressed where specified) affects product stability and efficacy.
• Stability and packaging: Curcumin degrades in light and oxygen exposure. Opaque, sealed containers limit light and air exposure. Check manufacturing and expiration dates.

See how 5 products score on these criteria →

Frequently Asked Questions